Programmed death ligand-1 (PD-L1) is well known for its role as an immune checkpoint regulator, but little is known about its function in other cellular processes. A study now shows that in tumour cells PD-L1 mediates pyroptosis, an inflammatory form of cell death, by activating the expression of Gasdermine C, ultimately leading to tumour necrosis.
References
Sharma, P. & Allison, J. P. Nat. Rev. Immunol. 20, 75–76 (2020).
Azuma, T. et al. Blood 111, 3635–3643 (2008).
Chang, C. H. et al. Cell 162, 1229–1241 (2015).
Orzechowski, A. & Dong, H. Cancer Res. 74, 5026 (2014); https://doi.org/10.1158/1538-7445.am2014-5026
Yu, J. et al. Cell Res. 30, 590–601 (2020).
Hou, J. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-020-0575-z (2020).
Edwards, J. G. et al. Chest 124, 1916–1923 (2003).
Shi, J., Gao, W. & Shao, F. Trends Biochem. Sci. 42, 245–254 (2017).
Xia, X. et al. Cell Death Dis. 10, 650 (2019).
Fuchs, Y. & Steller, H. Cell 147, 742–758 (2011).
Zhang, J. et al. Oncotarget 5, 9664–9677 (2014).
Brown, J. M. & Wilson, W. R. Nat. Rev. Cancer 4, 437–447 (2004).
Lee, A. H. S., Happerfield, L. C., Bobrow, L. G. & Millis, R. R. J. Clin. Pathol. 50, 669–673 (1997).
Karagiannis, G. S. et al. Sci. Transl. Med. 9, eaan0026 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Blasco, M.T., Gomis, R.R. PD-L1 controls cancer pyroptosis. Nat Cell Biol 22, 1157–1159 (2020). https://doi.org/10.1038/s41556-020-00582-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-020-00582-w
- Springer Nature Limited
This article is cited by
-
Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma
Journal of Cancer Research and Clinical Oncology (2023)
-
The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy
Journal of Hematology & Oncology (2022)
-
LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer
Scientific Reports (2022)